CAPS Medical Enrolls Patients from Sheba Medical Center in First Ever Study for Treatment of Bladder Cancer Using Selective Endoscopic Cancer Treatment Technology
CAPS Medical is gearing up for clinical trials of its breakthrough system that delivers non-thermal atmospheric plasma (NTAP™) to treat-tumors.
CAPS Medical receives Notice of Allowance for it’s first Global family of patents. The allowed applications cover CAPS Medical’s Non Thermal Plasma NTAP™ technology In US, Europe Asia and Israel.
Our CEO Ilan Uchitel took part in International Workshop on Plasma for Cancer Treatment (IWPCT-2021).
CAPS Medical is Revolutionizing Cancer Treatment
CAPS Medical Closes Funding Round to Conduct Clinical Study to Treat Cancer
Congratulations to our Executive Chairman, Harel Gadot, for being chosen as one of the TOP 25 VOICES IN HEALTHCARE ROBOTICS!
We are excited to welcome Boris Kogan as our new VP of Research and Development
We are excited to welcome Prof. S. Nahum Goldberg to the Scientific Advisory Board
CAPS Medical was featured in Season 4 of True Future: Israel.
Israeli Startup Aims to Treat Tumors Without a Surgery (Hebrew)
Caps Medical Closes $3.5M Series A Funding
Israeli startup scores $3.5M bringing non-invasive cancer solution to the table
CAPS Medical Completes $3.5 Million Series A Round for Selective Cancer Treatment Technology
We were excited to have Jacob Cohen MD. present CAPS Medical technology and it's advantage in selectively treating solid tumors at the Annual Meeting of The Israeli Society of Otolaryngology Head and Neck Surgery.
We were pleased to have CAPS Medical CEO Ilan Uchitel present our technology last week at a Rambam Medtech event highlighting young companies making an impact.
THE JERUSALEM POST
Israeli start-up creates new tech to target internal solid tumors
Investigation device use only, not cleared for marketing in USA and ROW